Symptoms of immune deficiency began when Dona Darr’s daughter, Emily, was just a toddler. What started as an ear infection turned into nearly a decade-long quest for an accurate diagnosis.
Dr. Dietrich Klinghardt, whose practice treats mostly late-stage Lyme patients after treatment has failed under the care of other healthcare practitioners, uses a systemic and local approach to treatment.
Regina Weichert suffered for years from the effects of Lyme disease but finally found a successful treatment from a doctor who utilized an out-of-the-box approach.
In the 21st century, it is anticipated that vaccines will play an equally significant role, addressing issues that include increased life expectancy, emerging infections and childhood mortality in developing countries.
Dr. Ronald Sokol’s life work revolves around the research and treatment of childhood liver diseases and other pediatric disorders.
This safety-themed edition of BioSupply Trends Quarterly addresses this patient safety and how it can be improved.
Major depressive disorder is a prevalent condition, but with swift and
appropriate treatment, the chance of recurrence can be minimized.
Mark Harris, PhD, is the founder and chief executive officer of NextGxDx, a healthcare information company that provides a web-based genetic diagnostics marketplace.
The stigma of depression left Deborah Gray suffering for 20 years with MDD before she was diagnosed.
Prior to penicillin, life expectancy was limited for patients with X-linked agammaglobulinemia. Thanks to the advent of intravenous immune globulin, the prognosis today is much more promising.
The Johnsons look like a picture-perfect family, but behind the smiles, this family faces the daily challenges, heartbreak and loss that come with a diagnosis of primary immunodeficiency
In this plasma-themed issue of BioSupplyTrends Quarterly, we take a critical look at each of these segments of the plasma market.
